Developmental toxicants and congenital pancreas malformations

发育毒物和先天性胰腺畸形

基本信息

项目摘要

Project Summary Early life stage exposures to xenobiotics can result in aberrant pancreatic development, which may predispose an individual to pancreatitis and metabolic dysfunction. A common mode of toxicity shared by numerous compounds is the generation of reactive oxygen species (ROS) and redox stress. ROS and cellular redox potential play fundamental roles in normal embryonic development and cell signaling. Perturbation of these processes resulting from xenobiotic exposure can alter cell fate decisions, resulting in functional or structural alterations that only become apparent with subsequent stress or age. However, surprisingly little is known about how embryos respond to redox stress, or the impact of xenobiotic exposures on pancreas development. Congenital pancreas malformations in humans are estimated to occur in approximately ten percent of the population and are associated with obesity, pancreatitis, Type 1 and Type 2 diabetes mellitus. The causes of these malformations are not well understood, and cannot be fully explained by genetic polymorphisms, suggesting a strong exogenous component. We have found that early life exposures to PFAS compounds and pro-oxidants results in a short exocrine pancreas. This grant takes a systems-level approach in transgenic zebrafish (Danio rerio) embryos to investigate a potential mechanism of oxidative stress in this deformity, and seeks to establish the functional outcomes of the truncated exocrine pancreas phenotype. Zebrafish are a well- established, widely used, and powerful model organism for studying vertebrate embryonic development in vivo. This work will facilitate advancement of a mechanistic understanding of how early-life xenobiotic exposures and redox stress can damage the developing pancreas and predispose humans to metabolic diseases.
项目摘要 早期生命阶段暴露于异生元可能会导致异常胰腺发育,这可能 倾向于胰腺炎和代谢功能障碍。一种共同的毒性模式 许多化合物是活性氧(ROS)和氧化还原应激的产生。 ROS和细胞 氧化还原潜在的发挥作用在正常的胚胎发育和细胞信号传导中。扰动 因异生物暴露而产生的这些过程可以改变细胞命运的决策,从而导致功能或 结构性改变只会随后的压力或年龄而显而易见。但是,令人惊讶的是 知道胚胎如何应对氧化还原胁迫或异种暴露对胰腺的影响 发展。 据估计,人类的先天性胰腺畸形估计发生在大约百分之十中 种群,与肥胖,胰腺炎,1型和2型糖尿病有关。原因 这些畸形尚未得到充分理解,不能用遗传多态性来完全解释 提示强大的外源成分。我们发现,早期的生命暴露于PFAS化合物和 促氧化剂导致外分泌胰腺短。该赠款采用转基因的系统级方法 斑马鱼(Danio rerio)胚胎研究这种畸形中氧化应激的潜在机制,并且 寻求建立截短的外分泌胰腺表型的功能结果。斑马鱼是一个很好的 建立,广泛使用且强大的模型生物体用于研究体内脊椎动物胚胎发育。 这项工作将有助于发展对早期生命植物生物暴露方式的机械理解 氧化还原压力会损害发育中的胰腺和人类对代谢性疾病的偏爱。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alicia R Timme-Laragy其他文献

37 - Perfluorooctanesulfonic Acid Alters Embryonic Redox Signaling and Pancreatic Organogenesis in the Zebrafish, Danio Rerio
  • DOI:
    10.1016/j.freeradbiomed.2015.10.074
  • 发表时间:
    2015-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Karilyn E Sant;Haydee Jacobs;Alicia R Timme-Laragy
  • 通讯作者:
    Alicia R Timme-Laragy

Alicia R Timme-Laragy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alicia R Timme-Laragy', 18)}}的其他基金

Toxicant disruption of receptor-mediated endocytosis in oogenesis and later life metabolic dysfunction
卵子发生和晚年代谢功能障碍中受体介导的内吞作用的毒性破坏
  • 批准号:
    10008145
  • 财政年份:
    2017
  • 资助金额:
    $ 19.11万
  • 项目类别:
Toxicant disruption of receptor-mediated endocytosis in oogenesis and later life metabolic dysfunction
卵子发生和晚年代谢功能障碍中受体介导的内吞作用的毒性破坏
  • 批准号:
    10246504
  • 财政年份:
    2017
  • 资助金额:
    $ 19.11万
  • 项目类别:
Toxicant disruption of receptor-mediated endocytosis in oogenesis and later life metabolic dysfunction
卵子发生和晚年代谢功能障碍中受体介导的内吞作用的毒性破坏
  • 批准号:
    9757769
  • 财政年份:
    2017
  • 资助金额:
    $ 19.11万
  • 项目类别:
Activation of Nrf2 during embryonic development - mechanisms and consequences
胚胎发育过程中 Nrf2 的激活 - 机制和后果
  • 批准号:
    10467508
  • 财政年份:
    2016
  • 资助金额:
    $ 19.11万
  • 项目类别:
Activation of Nrf2 during embryonic development: mechanisms and consequences
胚胎发育过程中 Nrf2 的激活:机制和后果
  • 批准号:
    9113725
  • 财政年份:
    2016
  • 资助金额:
    $ 19.11万
  • 项目类别:
Activation of Nrf2 during embryonic development: mechanisms and consequences
胚胎发育过程中 Nrf2 的激活:机制和后果
  • 批准号:
    9924600
  • 财政年份:
    2016
  • 资助金额:
    $ 19.11万
  • 项目类别:
Activation of Nrf2 during embryonic development - mechanisms and consequences
胚胎发育过程中 Nrf2 的激活 - 机制和后果
  • 批准号:
    10589883
  • 财政年份:
    2016
  • 资助金额:
    $ 19.11万
  • 项目类别:
Differential Sensitivity to Oxidative Stress during Embryonic Development
胚胎发育过程中对氧化应激的不同敏感性
  • 批准号:
    7751682
  • 财政年份:
    2009
  • 资助金额:
    $ 19.11万
  • 项目类别:
Differential Sensitivity to Oxidative Stress during Embryonic Development
胚胎发育过程中对氧化应激的不同敏感性
  • 批准号:
    8097330
  • 财政年份:
    2009
  • 资助金额:
    $ 19.11万
  • 项目类别:
Differential Sensitivity to Oxidative Stress during Embryonic Development
胚胎发育过程中对氧化应激的不同敏感性
  • 批准号:
    7886877
  • 财政年份:
    2009
  • 资助金额:
    $ 19.11万
  • 项目类别:

相似海外基金

Pathogenic Mechanisms of Craniometaphyseal Dysplasia
颅骨干骺端发育不良的发病机制
  • 批准号:
    10630298
  • 财政年份:
    2022
  • 资助金额:
    $ 19.11万
  • 项目类别:
Pathogenic Mechanisms of Craniometaphyseal Dysplasia
颅骨干骺端发育不良的发病机制
  • 批准号:
    10444184
  • 财政年份:
    2022
  • 资助金额:
    $ 19.11万
  • 项目类别:
Synthetic Lethal Targeting of p53 in Myelodysplasia
骨髓增生异常中 p53 的合成致死靶向
  • 批准号:
    8092579
  • 财政年份:
    2007
  • 资助金额:
    $ 19.11万
  • 项目类别:
Synthetic Lethal Targeting of p53 in Myelodysplasia
p53 在骨髓增生异常中的合成致死靶向
  • 批准号:
    7251375
  • 财政年份:
    2007
  • 资助金额:
    $ 19.11万
  • 项目类别:
Synthetic Lethal Targeting of p53 in Myelodysplasia
骨髓增生异常中 p53 的合成致死靶向
  • 批准号:
    7858453
  • 财政年份:
    2007
  • 资助金额:
    $ 19.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了